July 2008
Current Medical Literature: Gastroenterology;2008, Vol. 27 Issue 3, p82
Academic Journal
The article highlights studies related to cholangitis. In "Immunoglobulin G4-Associated Cholangitis: Clinical Profile and Response to Therapy," the researchers examined the clinical features, and in particular the response to steroid treatment, of patients with biliary stricturing caused by IAC. In another study the researchers report that liver function test results improved in all groups and that ursodeoxycholic acid (UDCA) was well-tolerated at all doses.


Related Articles

  • Ursodeoxycholic Acid Improves Liver Tests in Chronic Hepatitis: Results of a Randomised Controlled Trial. Bertolotti, M.; Morselli-Labate, A.M.; Rusticali, A.G.; Loria, P.; Carulli, N. // Clinical Drug Investigation;1999, Vol. 17 Issue 6, p425 

    Objective: The present study was designed to investigate the effect of ursodeoxycholic acid (UDCA), a drug widely utilised in the management of cholestatic conditions, on liver function tests and symptom relief in a group of patients with chronic hepatitis of different aetiologies. Patients and...

  • Gallbladder Carcinoma, Improving Diagnosis and Outcome. Mohamed, Abbas AR; Emran, Fawaz; Ghanem, Najeeb; Mohamed, Asim A.E. // Internet Journal of Surgery;2010, Vol. 23 Issue 2, p1 

    Objective: The purpose of this study is to determine the pattern of presentation of carcinoma of the gall bladder in Saudi patients and to assess the accuracy of diagnostic modalities, namely ultrasound and computerized scan, in detecting the disease, together with an extensive literature review...

  • Self audit: Testing times.  // Update;Dec2006, Vol. 73 Issue 6, p95 

    The article focuses on two medical problems, based on medical tests. One of the problems discusses the case of a 47 year old diabetic who is prescribed simvastatin for her raised cholesterol. The routine liver function monitoring shows ALP to be raised to 130. The other test is related to a 67...

  • AKT question relating to raised liver function tests. Houghton, Mike // InnovAiT;Mar2009, Vol. 2 Issue 3, p147 

    The article presents a question related to liver function tests.

  • Guidance on liver testing with glitazones is often ignored.  // Pulse;10/4/2004, Vol. 64 Issue 39, p20 

    Reports on guidance on the use of glitazones in Great Britain. Importance of liver testing.

  • Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change? Basu, Sandip; Bhattacharya, Anish // European Journal of Nuclear Medicine & Molecular Imaging;Jun2015, Vol. 42 Issue 7, p1160 

    The article presents a study demonstrating the use of ursodeoxycholic acid (UDCA) versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis (NC). It notes the pharmacological actions of UDCA including direct cytoprotection, detergent action on dysfunctional...

  • Single domain antibodies. Dick, Heather M. // BMJ: British Medical Journal (International Edition);4/14/90, Vol. 300 Issue 6730, p959 

    Focuses on single domain antibodies as an alternative to monoclonal antibodies in diagnosis and treatment in Great Britain. Properties of antibodies; Use of monoclonal antibodies in many diagnostic test kits; Production of a single domain antibody.

  • LEG ULCERS AND LIVER FUNCTION TESTS. Aronsen, K. F.; Gundersen, J.; Haeger, K. H. M. // Angiology;Feb1972, Vol. 23 Issue 2, p111 

    Examines the indications that crural ulcers may be associated with a disturbance of liver function. Dermatological manifestations of chronic hepatitis; Enhancement of the detection of a possible abnormal function of the liver; Evaluation of liver function in patients with vascular disorders of...

  • Are liver function tests required for patients taking isoniazid for latent TB? Brown, Maureen O.; Howard, Ellen // Journal of Family Practice;Jan2004, Vol. 53 Issue 1, p63 

    Routine liver function test monitoring is not required for all patients on isoniazid therapy for latent tuberculosis infection. No clinical trials have studied the potential risks and benefits of routinely monitoring liver function tests for all patients taking isoniazid for latent TB...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics